Incidence and prevalence of myasthenia gravis in the United States: A claims‐based analysis
Introduction/Aims Myasthenia gravis (MG) is a rare neuromuscular disorder with geographically variable prevalence and incidence rates. A global trend of increasing prevalence of MG has been observed in the last few decades, and this study aimed to assess the current prevalence and incidence rates of...
Gespeichert in:
Veröffentlicht in: | Muscle & nerve 2024-02, Vol.69 (2), p.166-171 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Introduction/Aims
Myasthenia gravis (MG) is a rare neuromuscular disorder with geographically variable prevalence and incidence rates. A global trend of increasing prevalence of MG has been observed in the last few decades, and this study aimed to assess the current prevalence and incidence rates of MG in the United States.
Methods
Data were extracted from the Clarivate Real‐World Data Repository (2016–2021), a US claims and electronic health records database. The prevalence and incidence of MG were calculated for the year 2021 for males and females who were |
---|---|
ISSN: | 0148-639X 1097-4598 |
DOI: | 10.1002/mus.28006 |